vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and EverQuote, Inc. (EVER). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $190.9M, roughly 1.5× EverQuote, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 9.8%, a 86.5% gap on every dollar of revenue. On growth, EverQuote, Inc. posted the faster year-over-year revenue change (14.5% vs 9.4%). Over the past eight quarters, EverQuote, Inc.'s revenue compounded faster (27.6% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
EverQuote, Inc. is an online insurance marketplace founded in 2011 and based in Cambridge, Massachusetts.
ACAD vs EVER — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $190.9M |
| Net Profit | $273.6M | $18.7M |
| Gross Margin | 90.8% | 97.8% |
| Operating Margin | 6.1% | 12.3% |
| Net Margin | 96.3% | 9.8% |
| Revenue YoY | 9.4% | 14.5% |
| Net Profit YoY | 90.3% | 133.7% |
| EPS (diluted) | $1.61 | $0.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $190.9M | ||
| Q4 25 | $284.0M | $195.3M | ||
| Q3 25 | $278.6M | $173.9M | ||
| Q2 25 | $264.6M | $156.6M | ||
| Q1 25 | $244.3M | $166.6M | ||
| Q4 24 | $259.6M | $147.5M | ||
| Q3 24 | $250.4M | $144.5M | ||
| Q2 24 | $242.0M | $117.1M |
| Q1 26 | — | $18.7M | ||
| Q4 25 | $273.6M | $57.8M | ||
| Q3 25 | $71.8M | $18.9M | ||
| Q2 25 | $26.7M | $14.7M | ||
| Q1 25 | $19.0M | $8.0M | ||
| Q4 24 | $143.7M | $12.3M | ||
| Q3 24 | $32.8M | $11.6M | ||
| Q2 24 | $33.4M | $6.4M |
| Q1 26 | — | 97.8% | ||
| Q4 25 | 90.8% | 97.7% | ||
| Q3 25 | 92.2% | 97.3% | ||
| Q2 25 | 92.2% | 96.9% | ||
| Q1 25 | 91.7% | 96.8% | ||
| Q4 24 | 91.6% | 96.3% | ||
| Q3 24 | 92.5% | 96.2% | ||
| Q2 24 | 92.5% | 95.7% |
| Q1 26 | — | 12.3% | ||
| Q4 25 | 6.1% | 9.5% | ||
| Q3 25 | 12.8% | 10.1% | ||
| Q2 25 | 12.2% | 9.0% | ||
| Q1 25 | 7.9% | 4.8% | ||
| Q4 24 | 59.1% | 8.2% | ||
| Q3 24 | 12.6% | 8.1% | ||
| Q2 24 | 12.6% | 5.4% |
| Q1 26 | — | 9.8% | ||
| Q4 25 | 96.3% | 29.6% | ||
| Q3 25 | 25.8% | 10.8% | ||
| Q2 25 | 10.1% | 9.4% | ||
| Q1 25 | 7.8% | 4.8% | ||
| Q4 24 | 55.4% | 8.3% | ||
| Q3 24 | 13.1% | 8.0% | ||
| Q2 24 | 13.8% | 5.5% |
| Q1 26 | — | $0.51 | ||
| Q4 25 | $1.61 | $1.53 | ||
| Q3 25 | $0.42 | $0.50 | ||
| Q2 25 | $0.16 | $0.39 | ||
| Q1 25 | $0.11 | $0.21 | ||
| Q4 24 | $0.86 | $0.35 | ||
| Q3 24 | $0.20 | $0.31 | ||
| Q2 24 | $0.20 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $178.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $240.9M |
| Total Assets | $1.6B | $324.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $178.5M | ||
| Q4 25 | $177.7M | $171.4M | ||
| Q3 25 | $258.0M | $145.8M | ||
| Q2 25 | $253.6M | $148.2M | ||
| Q1 25 | $217.7M | $125.0M | ||
| Q4 24 | $319.6M | $102.1M | ||
| Q3 24 | $155.1M | $82.8M | ||
| Q2 24 | $177.1M | $60.9M |
| Q1 26 | — | $240.9M | ||
| Q4 25 | $1.2B | $238.0M | ||
| Q3 25 | $917.3M | $174.9M | ||
| Q2 25 | $822.4M | $170.3M | ||
| Q1 25 | $765.2M | $149.5M | ||
| Q4 24 | $732.8M | $135.4M | ||
| Q3 24 | $577.2M | $117.7M | ||
| Q2 24 | $516.7M | $100.8M |
| Q1 26 | — | $324.0M | ||
| Q4 25 | $1.6B | $326.9M | ||
| Q3 25 | $1.3B | $256.1M | ||
| Q2 25 | $1.2B | $241.4M | ||
| Q1 25 | $1.1B | $232.1M | ||
| Q4 24 | $1.2B | $210.5M | ||
| Q3 24 | $976.9M | $180.5M | ||
| Q2 24 | $914.1M | $158.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $29.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | 1.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $29.6M | ||
| Q4 25 | $-48.7M | $27.0M | ||
| Q3 25 | $74.3M | $19.8M | ||
| Q2 25 | $64.0M | $25.3M | ||
| Q1 25 | $20.3M | $23.3M | ||
| Q4 24 | $40.4M | $20.1M | ||
| Q3 24 | $63.2M | $23.6M | ||
| Q2 24 | $25.0M | $12.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $25.8M | ||
| Q3 25 | $73.9M | $18.5M | ||
| Q2 25 | — | $23.8M | ||
| Q1 25 | — | $22.2M | ||
| Q4 24 | — | $19.1M | ||
| Q3 24 | $63.2M | $22.1M | ||
| Q2 24 | — | $11.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 13.2% | ||
| Q3 25 | 26.5% | 10.6% | ||
| Q2 25 | — | 15.2% | ||
| Q1 25 | — | 13.3% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | 25.2% | 15.3% | ||
| Q2 24 | — | 9.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | 1.59× | ||
| Q4 25 | -0.18× | 0.47× | ||
| Q3 25 | 1.03× | 1.05× | ||
| Q2 25 | 2.40× | 1.72× | ||
| Q1 25 | 1.07× | 2.92× | ||
| Q4 24 | 0.28× | 1.64× | ||
| Q3 24 | 1.93× | 2.04× | ||
| Q2 24 | 0.75× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
EVER
| Automotive | $172.4M | 90% |
| Home and renters | $18.5M | 10% |
